Search company, investor...

Axikin Pharmaceuticals

axikin.com

Founded Year

2008

Stage

Series C | Alive

Total Raised

$13.5M

Last Raised

$6.5M | 10 yrs ago

About Axikin Pharmaceuticals

Axikin Pharmaceuticals is a biopharmaceutical company focused on the development of therapeutics for respiratory disorders including allergic rhinitis, ashtam and COPD. The Axikin discovery biology and portfolio of small molecules focuses on GPCR and kinase targets central to the inflammatory process, the antagonism of which is predicted to ameliorate allergic respiratory disorders such as rhinitis and asthma, in addition to significantly impacting the inflammation observed in COPD. Axikin was created as a spin-off from Actimis Pharmaceuticals, following the structured acquisition of Actimis by Boehringer Ingelheim. Actimis was originally spun out of the respiratory diseases therapeutic research portfolio of Bayer Healthcare.

Headquarters Location

10835 Road To The Cure Suite 250

San Diego, California, 92121,

United States

858-458-1890

Loading...

Loading...

Axikin Pharmaceuticals Patents

Axikin Pharmaceuticals has filed 16 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/29/2016

8/15/2017

Transcription factors, Human proteins, Clusters of differentiation, Proteins, Protein kinase inhibitors

Grant

Application Date

11/29/2016

Grant Date

8/15/2017

Title

Related Topics

Transcription factors, Human proteins, Clusters of differentiation, Proteins, Protein kinase inhibitors

Status

Grant

Latest Axikin Pharmaceuticals News

Axikin Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250

Nov 16, 2018

17:44 EST 16 Nov 2018 | BioPortfolio Reports Summary Axikin Pharmaceuticals Inc Axikin is a biopharmaceutical company that develops small molecule therapeutics for respiratory disorders. The company offers preclinical and research programs with small molecule therapeutics for applications in asthma , chronic obstructive pulmonary disease, inflammatory dermatoses, inflammatory bowel disease, and rheumatoid arthritis. Its research areas include asthma and COPD that comprise chronic inflammatory disorder of the airways in which patients may experience acute exacerbations and diseases including emphysema and chronic bronchitis reflecting a progressive and irreversible loss of airway function that might result in death. Axikin Pharmaceuticals is headquartered in San Diego, California, the US. Axikin Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Axikin Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Axikin Pharmaceuticals founded?

    Axikin Pharmaceuticals was founded in 2008.

  • Where is Axikin Pharmaceuticals's headquarters?

    Axikin Pharmaceuticals's headquarters is located at 10835 Road To The Cure, San Diego.

  • What is Axikin Pharmaceuticals's latest funding round?

    Axikin Pharmaceuticals's latest funding round is Series C.

  • How much did Axikin Pharmaceuticals raise?

    Axikin Pharmaceuticals raised a total of $13.5M.

  • Who are the investors of Axikin Pharmaceuticals?

    Investors of Axikin Pharmaceuticals include Sanderling Ventures, Mitsui & Co. Global Investment and Actimis Pharmaceuticals.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.